HUMA
USDHumacyte Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$1.300
Máximo
$1.340
Mínimo
$1.220
Volumen
3.25M
Fundamentos de la Empresa
Capitalización de Mercado
249.1M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
5.40M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
BTIG Maintains Buy on Humacyte, Lowers Price Target to $6
BTIG analyst Ryan Zimmerman maintains Humacyte with a Buy and lowers the price target from $7 to $6.
Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering
DURHAM, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today
D. Boral Capital Maintains Buy on Humacyte, Maintains $25 Price Target
D. Boral Capital analyst Jason Kolbert maintains Humacyte with a Buy and maintains $25 price target.
Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus
– Patent covers esophagus produced using Humacyte's proprietary bioengineered regenerative tissue platform, designed for implant in patients with damaged esophagus –
Acciones Relacionadas
NSA
National Storage Affiliates Trust Common Shares of Beneficial Interest
NTRB
Nutriband Inc.
EVAX
Evaxion Biotech A/S American Depositary Share
SPOK
Spok Holdings Inc.
KRP
Kimbell Royalty Partners Common Units Representing Limited Partner Interests
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.